CoChat

Employing a superior BACE1 cleavage sequence to probe cellular APP processing

Tomasselli, Alfredo G., Qahwash, Isam, Emmons, Thomas L., Lu, Yifeng, Leone, Joseph W., Lull, June M., Fok, Kam F., Bannow, Carol A., Smith, Clark W., Bienkowski, Michael J., Heinrikson, Robert L., Yan, Riqiang · 2003 · Journal of Neurochemistry
Cited by 53

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

The involvement of β‐secretase (BACE1; β‐site APP‐cleaving enzyme) in producing the β‐amyloid component of plaques found in the brains of Alzheimer's patients, has fueled a major research effort to characterize this protease. Here, we describe work toward understanding the substrate specificity of BACE1 that began by considering the natural APP substrate and its Swedish mutant, APP Sw, and proceeded on to include oxidized insulin B chain and ubiquitin substrates. From these findings, and the study of additional synthetic peptides, we determined that a decapeptide derived from APP in which the P3‐P2′ sequence, …VKM‐↓‐DA…, was replaced by …ISY‐↓‐EV… (‐↓‐ = β site of cleavage), yielded a substrate that was cleaved by BACE1 seven times faster than the corresponding APP Sw peptide, SEVNL‐↓‐DAEFR. The expanded peptide, GLTNIKTEEI SEISY‐↓‐EVEFR WKK, was cleaved an additional seven times faster than its decapeptide counterpart (boldface), and provides a substrate allowing assay of BACE1 at picomolar concentrations. Several APP mutants reflecting these β‐site amino acid changes were prepared as the basis for cellular assays. The APP ISYEV mutant proved to be a cellular substrate that was superior to APP Sw. The assay based on APP ISYEV is highly specific for measuring BACE1 activity in cells; its homolog, BACE2, barely cleaved APP ISYEV at the β‐site. Insertion of the optimized ISY‐↓‐EV motif at either the β‐site (Asp1) or β′‐site (Glu11) directs the rate of cellular processing of APP at these two accessible sites. Thus, we have identified optimal BACE1 substrates that will be useful to elucidate the cellular enzymatic actions of BACE1, and for design of inhibitors that might be of therapeutic benefit in Alzheimer's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1471-4159.2003.01597.x

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 53

Metadata

Authors
Tomasselli, A. G., Qahwash, I., Emmons, T. L., Lu, Y., Leone, J. W., Lull, J. M., Fok, K. F., Bannow, C. A., Smith, C. W., Bienkowski, M. J., Heinrikson, R. L., & Yan, R.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2003-02-18
Volume
84
Issue
5
Pages
1006-1017
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1958181441
Cited by
53
References
10
FWCI
1.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Employing a superior BACE1 cleavage sequence to probe cellular APP processing. https://app.cochat.ai/papers/10.1046/j.1471-4159.2003.01597.x
The paper
Tomasselli, A. G., Qahwash, I., Emmons, T. L., Lu, Y., Leone, J. W., Lull, J. M., Fok, K. F., Bannow, C. A., Smith, C. W., Bienkowski, M. J., Heinrikson, R. L., & Yan, R. (2003). Employing a superior BACE1 cleavage sequence to probe cellular APP processing. Journal of Neurochemistry. https://doi.org/10.1046/j.1471-4159.2003.01597.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.